Further, to identify key genes related to the prognosis of PAAD patients, we analyzed the overall survival between differentially expressed immune checkpoint (OX40, KIR3DL1, and TNFRSF14) groups. Here, TNFRSF14 is linked to pancreatic adenocarcinoma.